These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33556240)

  • 1. Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer.
    DeCarlo A; Malardier-Jugroot C; Szewczuk MR
    Bioconjug Chem; 2021 Mar; 32(3):512-522. PubMed ID: 33556240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Multimodality of Nanomedicine Therapy: Size and Structure Dependence of Folic Acid Conjugated Copolymers Actively Target Cancer Cells in Disabling Cell Division and Inducing Apoptosis.
    Sambi M; DeCarlo A; Malardier-Jugroot C; Szewczuk MR
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31683806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform.
    Li X; Szewczuk MR; Malardier-Jugroot C
    Drug Des Devel Ther; 2016; 10():4101-4110. PubMed ID: 28008233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized Folic Acid-Conjugated Amphiphilic Alternating Copolymer Actively Targets 3D Multicellular Tumour Spheroids and Delivers the Hydrophobic Drug to the Inner Core.
    Li X; Sambi M; DeCarlo A; Burov SV; Akasov R; Markvicheva E; Malardier-Jugroot C; Szewczuk MR
    Nanomaterials (Basel); 2018 Aug; 8(8):. PubMed ID: 30072655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
    Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
    Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles.
    Akbarian A; Ebtekar M; Pakravan N; Hassan ZM
    Int J Biol Macromol; 2020 Jun; 152():90-101. PubMed ID: 32057865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(l-lysine)-graft-folic acid-coupled poly(2-methyl-2-oxazoline) (PLL-g-PMOXA-c-FA): a bioactive copolymer for specific targeting to folate receptor-positive cancer cells.
    Chen Y; Cao W; Zhou J; Pidhatika B; Xiong B; Huang L; Tian Q; Shu Y; Wen W; Hsing IM; Wu H
    ACS Appl Mater Interfaces; 2015 Feb; 7(4):2919-30. PubMed ID: 25581478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
    Shen Z; Li Y; Kohama K; Oneill B; Bi J
    Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycopolymer decorated multiwalled carbon nanotubes for dual targeted breast cancer therapy.
    Omurtag Ozgen PS; Atasoy S; Zengin Kurt B; Durmus Z; Yigit G; Dag A
    J Mater Chem B; 2020 Apr; 8(15):3123-3137. PubMed ID: 32211704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid inhibits nasopharyngeal cancer cell proliferation and invasion via activation of FRα/ERK1/2/TSLC1 pathway.
    Liu Z; Jin X; Pi W; Liu S
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29070520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the value of competition assays in folate receptor-mediated drug delivery.
    Jones SK; Sarkar A; Feldmann DP; Hoffmann P; Merkel OM
    Biomaterials; 2017 Sep; 138():35-45. PubMed ID: 28551461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of folic acid functionalized terbium-doped dendritic fibrous nano-silica and Interaction with HEK 293 normal, MDA breast cancer and HT 29 colon cancer cells.
    Azizi S; Soleymani J; Shadjou N
    J Mol Recognit; 2020 Nov; 33(11):e2871. PubMed ID: 32677119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
    Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X
    Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flower-like curcumin-loaded folic acid-conjugated ZnO-MPA- βcyclodextrin nanostructures enhanced anticancer activity and cellular uptake of curcumin in breast cancer cells.
    Ghaffari SB; Sarrafzadeh MH; Fakhroueian Z; Khorramizadeh MR
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109827. PubMed ID: 31349522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro.
    Kamen BA; Smith AK
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):113-20. PubMed ID: 22644798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of a pH responsive folic acid functionalized polymeric drug delivery system.
    Li X; McTaggart M; Malardier-Jugroot C
    Biophys Chem; 2016; 214-215():17-26. PubMed ID: 27183249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.
    Hijaz M; Das S; Mert I; Gupta A; Al-Wahab Z; Tebbe C; Dar S; Chhina J; Giri S; Munkarah A; Seal S; Rattan R
    BMC Cancer; 2016 Mar; 16():220. PubMed ID: 26979107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study.
    Al-Thiabat MG; Gazzali AM; Mohtar N; Murugaiyah V; Kamarulzaman EE; Yap BK; Rahman NA; Othman R; Wahab HA
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.